Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Heart Technology

This article was originally published in The Gray Sheet

Executive Summary

Is beginning clinical trials of its Percutaneous Rotational Thrombectomy (PRT) device in the first quarter of this year under an investigational device exemption approved "at the end of last year," President Alan Levy announced at the Piper Jaffray investment conference. The device incorporates a flexible wire that is rotated at 5,000 revolutions per minute to treat arterial blood clots. The exec also reported that Heart Technology has received approval from FDA to resume clinical trials of its Rotablator atherectomy device for coronary applications and sales of the product for peripheral applications. The firm discontinued distribution of the device following a June recall and subsequently revised its manufacturing procedures in November to address the problem that led to the recall ("The Gray Sheet" Nov. 23, I&W-5).

You may also be interested in...

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.

Start-Up Spotlight: Iraq War Veteran Deploys ‘Bone Paint’ To Combat Traumatic Injuries

Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts